REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
July 23, 2024
FROM
ANDREW GOLDFRACH, ARMC Chief Executive Officer, Arrowhead Regional Medical Center
SUBJECT
Title
Amendment to Supply Agreement with Haemonetics Corporation for Reagents, Supplies, and Preventative Maintenance Services for TEG 6s Analyzers
End
RECOMMENDATION(S)
Recommendation
Approve Amendment No. 1 to Supply Agreement No. 22-689 with Haemonetics, Corporation for reagents, supplies, and preventative maintenance services for two TEG 6s Analyzers, to increase the not to exceed contract amount by $130,000, from $392,134 to $522,134, with no change to the contract period of July 12, 2022 through July 30, 2025.
(Presenter: Andrew Goldfrach, ARMC Chief Executive Officer, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General Funding (Net County Cost). The cost of $130,000 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2024-25 budget and will be included in the 2025-26 recommended budget.
BACKGROUND INFORMATION
Approval of Amendment No. 1 (Amendment) to Agreement No. 22-689 (Agreement) with Haemonetics Corporation (Haemonetics) will allow ARMC to continue to purchase reagents, supplies, and preventative maintenance services for two TEG 6s Analyzers. The supplies listed as part of the original agreement include products used as part of the chemical analysis.
Reagents are substances or mixtures that are used in the ARMC Laboratory for chemical analysis. The analyzers are comprised of a testing system for specific platelet functions in trauma and surgical patients. Platelets are cell fragments in the blood that form clots and stop or prevent bleeding. This Amendment will provide the ARMC Laboratory Department with the ongoing ability to provide platelet function test data to physicians who assess treatment for trauma or surgical patients.
On July 12, 2022 (Item No. 11), as the result of a non-competitive procurement, the Board of Supervisors (Board) approved the Agreement with Haemonetics, including the non-standard terms, for reagents, supplies, and preventative maintenance services for two TEG 6s Analyzers, for a not to exceed contract amount of $392,134, for a total contract period of July 12, 2022, through July 30, 2025.
ARMC recommends approval of the Amendment to continue to provide for the health and safety of County residents by ensuring the hospital has access to necessary supplies and reagents for patient testing.
PROCUREMENT
Not applicable.
REVIEW BY OTHERS
This item has been reviewed by County Counsel (Charles Phan, Supervising Deputy County Counsel, 387-5455) on June 27, 2024; Purchasing (Veronica Pedace, Buyer III, 387-2464 ) on June 28, 2024; ARMC Finance (Chen Wu, Finance and Budget Officer, 580-3165) on July 1, 2024; Finance (Jenny Yang, Administrative Analyst, 387-4884) on July 1, 2024; and County Finance and Administration (Paloma Hernandez-Barker, Deputy Executive Officer, 387-5423) on June 3, 2024.